| Dr Morgan M Garrett, DO | |
|
11 Charley Harper Dr Se, Cartersville, GA 30120-1122 | |
| (678) 719-0087 | |
| Not Available |
| Full Name | Dr Morgan M Garrett |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 14 Years |
| Location | 11 Charley Harper Dr Se, Cartersville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184991879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | UO2554 (Florida) | Secondary |
| 207P00000X | Emergency Medicine | 72255 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cartersville Medical Center | Cartersville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allatoona Emergency Group Pc | 2567847684 | 16 |
| Wellstreet Of Georgia Pc | 7517126279 | 377 |
| Maxfield Medical Llc | 7618333121 | 3 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050411000056 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
| Entity Name | Wellstreet Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235411547 PECOS PAC ID: 7517126279 Enrollment ID: O20120315000603 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
| Entity Name | Mount Lassen Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730598590 PECOS PAC ID: 6305160227 Enrollment ID: O20150126001140 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
| Entity Name | Allatoona Emergency Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487381349 PECOS PAC ID: 2567847684 Enrollment ID: O20220909001871 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
| Entity Name | Maxfield Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619673035 PECOS PAC ID: 7618333121 Enrollment ID: O20230525000003 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Morgan M Garrett, DO 4734 Duran Ct Ne, Marietta, GA 30066-1623 Ph: (772) 342-0767 | Dr Morgan M Garrett, DO 11 Charley Harper Dr Se, Cartersville, GA 30120-1122 Ph: (678) 719-0087 |
News Archive
Optimer Pharmaceuticals, announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company's novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection.
Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms.
The unwanted activation of an important cell-signaling pathway may play a role in two kidney problems that are major causes of end-stage renal disease, scientists at the Albert Einstein College of Medicine of Yeshiva University have found.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
As part of the continuing series, "Are You Covered?" Kaiser Health News and NPR profile Dave Koenig. He has a job with good benefits. Still, he thinks some aspects of the insurance industry should be changed to protect patients from losing coverage" (Weiss, 9/28). Watch the video.
› Verified 4 days ago
Dr. Jason E Conley, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 770-606-2104 | |
Amy M Hess, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 84 Lake Haven Dr, Cartersville, GA 30120 Phone: 770-334-2618 | |
Dr. Sherri Lynn Barton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1328 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 770-382-0029 | |
Lori Kuczmanski, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 60 Joe Frank Harris Parkway, Cartersville, GA 30120 Phone: 770-606-2104 |